MTFMT expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.50950363320135E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.90700000000299E-05 |
Normal-vs-Stage2 |
2.865700E-02 |
Normal-vs-Stage3 |
3.21964677141295E-15 |
Normal-vs-Stage4 |
1.63189461943603E-11 |
Stage1-vs-Stage2 |
9.841400E-01 |
Stage1-vs-Stage3 |
6.53809999473509E-08 |
Stage1-vs-Stage4 |
2.24780000002145E-06 |
Stage2-vs-Stage3 |
2.965000E-03 |
Stage2-vs-Stage4 |
3.424200E-03 |
Stage3-vs-Stage4 |
9.724600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.3315015756632E-11 |
Normal-vs-AfricanAmerican |
2.14909999999291E-05 |
Normal-vs-Asian |
4.689600E-01 |
Caucasian-vs-AfricanAmerican |
9.501600E-01 |
Caucasian-vs-Asian |
4.674200E-01 |
AfricanAmerican-vs-Asian |
4.447400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.89097692638552E-12 |
Normal-vs-Female |
1.46149999991074E-07 |
Male-vs-Female |
1.459440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.042910E-04 |
Normal-vs-Age(41-60Yrs) |
6.36819996735483E-09 |
Normal-vs-Age(61-80Yrs) |
1.18309995134069E-09 |
Normal-vs-Age(81-100Yrs) |
2.784100E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.238800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.042800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.826200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.358800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.541400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.709400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.717200E-03 |
Normal-vs-Grade 2 |
1.980330E-04 |
Normal-vs-Grade 3 |
1.18149934280609E-11 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
6.014200E-01 |
Grade 1-vs-Grade 3 |
3.840600E-01 |
Grade 1-vs-Grade 4 |
2.839100E-03 |
Grade 2-vs-Grade 3 |
6.794500E-04 |
Grade 2-vs-Grade 4 |
8.51879677910006E-11 |
Grade 3-vs-Grade 4 |
4.38170000000015E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.844100E-03 |
Normal-vs-ccB subtype |
3.40893979711154E-12 |
ccA subtype-vs-ccB subtype |
7.47699999692486E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.96930036114418E-10 |
Normal-vs-N1 |
7.617000E-03 |
N0-vs-N1 |
1.643200E-01 |
|
|